Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Adverse Drug Events Reporting News
Anti-IL-1 Drug May Be Better in RA With Type 2 DiabetesBlocking the IL-1 pathway with anakinra appeared to be more effective in a small study of patients who had rheumatoid arthritis and type 2 diabetes than in those with RA alone.
Medscape Medical News, October 2019
Eighty Years On, the Debate Over ECT ContinuesTo its many advocates, ECT is perhaps the most effective treatment in psychiatry. Its critics argue this can come at a substantial cost. Is this disagreement intractable?
Lung Cancer Therapy Makes Major AdvancesDr Suresh Ramalingam discusses the findings presented at two recent meetings that offer new treatment options for patients with lung cancer.
